2006
DOI: 10.1038/nature04657
|View full text |Cite
|
Sign up to set email alerts
|

A small-molecule screen in C. elegans yields a new calcium channel antagonist

Abstract: Small-molecule inhibitors of protein function are powerful tools for biological analysis and can lead to the development of new drugs. However, a major bottleneck in generating useful small-molecule tools is target identification. Here we show that Caenorhabditis elegans can provide a platform for both the discovery of new bioactive compounds and target identification. We screened 14,100 small molecules for bioactivity in wild-type worms and identified 308 compounds that induce a variety of phenotypes. One com… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

4
251
0

Year Published

2006
2006
2016
2016

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 268 publications
(255 citation statements)
references
References 25 publications
4
251
0
Order By: Relevance
“…A natural extension of this approach would be to adopt its use within a more highthroughput context, such as a microfluidics or a multiwell plate format. Currently, such high-throughput screens in C. elegans are limited to a single endpoint (i.e., paralysis) (Kwok et al 2006) or death (Petrascheck et al 2007). Screens that provide more detailed phenotypic discrimination would allow the identification of small molecules that exert more specific or subtle effects on locomotion phenotypes caused by either endogenous genetic mutations or transgene-based disease models.…”
Section: Resultsmentioning
confidence: 99%
“…A natural extension of this approach would be to adopt its use within a more highthroughput context, such as a microfluidics or a multiwell plate format. Currently, such high-throughput screens in C. elegans are limited to a single endpoint (i.e., paralysis) (Kwok et al 2006) or death (Petrascheck et al 2007). Screens that provide more detailed phenotypic discrimination would allow the identification of small molecules that exert more specific or subtle effects on locomotion phenotypes caused by either endogenous genetic mutations or transgene-based disease models.…”
Section: Resultsmentioning
confidence: 99%
“…Recently, a large-scale small-molecule screen in C. elegans has successfully isolated a calcium channel blocker. Subsequent suppressor genetic screens also identify the α 1 -subunit of the L-type calcium channel as a potential drug target (44). Interestingly, when the mDISC1 transgenic animals were incubated with rolipram, a well-known phosphodiesterase 4 (PDE4)- (13).…”
Section: Discussionmentioning
confidence: 99%
“…Today, a range of molecular phenotyping tools is available to characterize mutations. Although gene expression and protein profiling are predominantly used (3)(4)(5), metabonomic and metabolomic strategies (6, 7) advantageously produce metabolic fingerprints that allow identification of variations in low-molecular-weight compounds in biofluids or organs in response to pathophysiological events (8), drug treatments (9), or genetic polymorphisms (10). It is therefore an attractive hypothesis-free approach for large-scale functional genomics in model organisms (11).…”
mentioning
confidence: 99%